Self-sterilizing microneedle sensing patches for machine learning-enabled wound pH visual monitoring
We proposed to specify in new 425.600(h)(2), for agreement periods beginning on or after January 1, 2027, if an ACO is determined to be experienced with performance-based risk Medicare ACO initiatives, the ACO may enter either the BASIC track Level E for all performance years of the agreement period, or the ENHANCED track, subject to the proposed exception prohibiting ACOs with fewer than 5,000 assigned beneficiaries in BY1, BY2, or both, from participating in the ENHANCED track specified in new 425.600(h)(3) (described in section III.F.4.b.(2).(b) of the CY 2026 PFS proposed rule)
In the REDEFINE 2 trial involving participants with type 2 diabetes, CagriSema significantly reduced HbA1c beyond what semaglutide alone achieved
The product comes from controlled sterile manufacturing with clear documentation
Trademark Information: Setria is a registered trademark of Kyowa Hakko Bio Co., Ltd